Timely delivery: Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug

Aug 06, 2012
Timely delivery: Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug

(Phys.org) -- Many drug candidates fail because of low solubility or poor pharmacokinetic behavior. Ron Raines and colleagues at the University of Wisconsin–Madison (USA) have devised a new prodrug strategy to overcome these limitations. Their approach takes advantage of the capacity of an enzyme prevalent in human serum–pancreatic-type ribonuclease—to catalyze the cleavage of a drug conjugated to a ribonucleoside 3'-phosphate; the results of their work are reported in ChemMedChem.

They demonstrated efficacy by using metronidazole, a sparingly soluble antibiotic that is often administered orally. In the absence of ribonuclease, metronidazole conjugates are stable and inactive. Physiological levels of enzyme render the conjugate toxic to Bacteroides fragilis, a common penicillin-resistant bacillus that is responsible for anaerobic infections. Alterations to the ribonucleoside enable modulation of key attributes, such as the rate of drug delivery.

This study paves the way for further research into the activation and timed release of drugs of varying aqueous .

Explore further: A closer look at a deadly bacterium sets the stage for new vaccines

More information: Ronald T. Raines, Ribonucleoside 3'-Phosphates as Pro-Moieties for an Orally Administered Drug, ChemMedChem 2012, 7, No. 8, dx.doi.org/10.1002/cmdc.201200243

Related Stories

Researchers make neurological disease breakthrough

Oct 07, 2011

(Medical Xpress) -- Results of a study by a group of University of Notre Dame researchers represent a promising step on the road to developing new drugs for a variety of neurological diseases.

Research team gives drug dropouts a second chance

May 07, 2012

(Phys.org) -- A cross-disciplinary team of researchers at the University of Maryland has designed a molecular container that can hold drug molecules and increase their solubility, in one case up to nearly ...

Recommended for you

What happens inside a membrane

May 20, 2015

A new SISSA study has achieved two important results with a single effort: to devise an innovative method to analyse the structure of biological proteins immersed in their physiological context, and to closely ...

Biomedical sensors for disease detection made simple

May 19, 2015

Healthcare researchers are increasingly focused on the early detection and prevention of illnesses. Early and accurate diagnosis is vital, especially for people in developing countries where infectious diseases ...

Studying dynamics of ion channels

May 18, 2015

Scientists from the Vaziri lab at the Vienna Biocenter, together with colleagues at the Institute for Biophysical Dynamics at the University of Chicago, have developed a method using infrared spectroscopy ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.